These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 16841080

  • 21. Vaccine-induced CD8+ T cell-dependent suppression of airway hyperresponsiveness and inflammation.
    Takeda K, Dow SW, Miyahara N, Kodama T, Koya T, Taube C, Joetham A, Park JW, Dakhama A, Kedl RM, Gelfand EW.
    J Immunol; 2009 Jul 01; 183(1):181-90. PubMed ID: 19542429
    [Abstract] [Full Text] [Related]

  • 22. Coexpression of Flt3 ligand and GM-CSF genes modulates immune responses induced by HER2/neu DNA vaccine.
    Yo YT, Hsu KF, Shieh GS, Lo CW, Chang CC, Wu CL, Shiau AL.
    Cancer Gene Ther; 2007 Nov 01; 14(11):904-17. PubMed ID: 17704754
    [Abstract] [Full Text] [Related]

  • 23. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
    Seo SH, Jin HT, Park SH, Youn JI, Sung YC.
    Vaccine; 2009 Sep 25; 27(42):5906-12. PubMed ID: 19651174
    [Abstract] [Full Text] [Related]

  • 24. DNA vaccine expressing repeated carcinoembryonic antigen (CEA)(625-667) induces strong immunity in mice.
    Li D, Hua S, Fan Y, Xu S, Duan X, Liu L, Che Y, Li S, Tan Y.
    Immunol Lett; 2011 Mar 30; 135(1-2):124-8. PubMed ID: 21073899
    [Abstract] [Full Text] [Related]

  • 25. Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.
    Fotin-Mleczek M, Duchardt KM, Lorenz C, Pfeiffer R, Ojkić-Zrna S, Probst J, Kallen KJ.
    J Immunother; 2011 Jan 30; 34(1):1-15. PubMed ID: 21150709
    [Abstract] [Full Text] [Related]

  • 26. 'Survival gene' Bcl-xl potentiates DNA-raised antitumor immunity.
    Kim JH, Chen J, Majumder N, Lin H, Falo LD, You Z.
    Gene Ther; 2005 Oct 30; 12(20):1517-25. PubMed ID: 16052205
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen.
    Bråve A, Hallengärd D, Gudmundsdotter L, Stout R, Walters R, Wahren B, Hallermalm K.
    Vaccine; 2009 Jun 08; 27(28):3692-6. PubMed ID: 19428161
    [Abstract] [Full Text] [Related]

  • 29. Cationic lipid:bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal tumor models.
    Lanuti M, Rudginsky S, Force SD, Lambright ES, Siders WM, Chang MY, Amin KM, Kaiser LR, Scheule RK, Albelda SM.
    Cancer Res; 2000 Jun 01; 60(11):2955-63. PubMed ID: 10850443
    [Abstract] [Full Text] [Related]

  • 30. DNA vaccines targeting tumor antigens to B7 molecules on antigen-presenting cells induce protective antitumor immunity and delay onset of HER-2/Neu-driven mammary carcinoma.
    Sloots A, Mastini C, Rohrbach F, Weth R, Curcio C, Burkhardt U, Jäger E, Forni G, Cavallo F, Wels WS.
    Clin Cancer Res; 2008 Nov 01; 14(21):6933-43. PubMed ID: 18980988
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Interleukin-18 enhances Th1 immunity and tumor protection of a DNA vaccine.
    Marshall DJ, Rudnick KA, McCarthy SG, Mateo LR, Harris MC, McCauley C, Snyder LA.
    Vaccine; 2006 Jan 16; 24(3):244-53. PubMed ID: 16135392
    [Abstract] [Full Text] [Related]

  • 36. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene.
    Chen CH, Wang TL, Hung CF, Yang Y, Young RA, Pardoll DM, Wu TC.
    Cancer Res; 2000 Feb 15; 60(4):1035-42. PubMed ID: 10706121
    [Abstract] [Full Text] [Related]

  • 37. Enhancement of DNA vaccine potency through linkage of antigen gene to ER chaperone molecules, ER-60, tapasin, and calnexin.
    Lin CT, Chang TC, Chao A, Dzeng E, Soong YK, Hung CF, Lai CH.
    J Biomed Sci; 2005 Feb 15; 12(2):279-87. PubMed ID: 15918000
    [Abstract] [Full Text] [Related]

  • 38. Enhanced antimetastatic effect of fetal liver kinase 1 extracellular domain and interferon-gamma fusion gene-modified dendritic cell vaccination.
    Pan J, Heiser A, Marget M, Steinmann J, Kabelitz D.
    Gene Ther; 2005 May 15; 12(9):742-50. PubMed ID: 15729371
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. In vivo effects of vaccination with six-transmembrane epithelial antigen of the prostate: a candidate antigen for treating prostate cancer.
    Garcia-Hernandez Mde L, Gray A, Hubby B, Kast WM.
    Cancer Res; 2007 Feb 01; 67(3):1344-51. PubMed ID: 17283172
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.